CVE-2023-26913

Name: CVE-2023-26913
Creator: NVD / NIST
Published: 2023-03-22T15:15:10.357+00:00
License: https://creativecommons.org/publicdomain/zero/1.0/

MEDIUMCVSS 6.1/10EPSS 0.49%

Last modified Jun 17, 2026

CVE-2023-26913 is a medium-severity vulnerability rated 6.1/10 on the CVSS scale. EVOLUCARE ECSIMAGING (aka ECS Imaging) < 6.21.5 is vulnerable to Cross Site Scripting (XSS) via new_movie. php.. EPSS estimates a 0.49% chance of exploitation in the next 30 days.

Description

EVOLUCARE ECSIMAGING (aka ECS Imaging) < 6.21.5 is vulnerable to Cross Site Scripting (XSS) via new_movie. php.

Metrics

CVSS 3.1

6.1/10

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N

EPSS Probability

0.49%

38.5th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

CWE-79

Affected Software

Vendor	Product	Versions
Evolucare	Ecs Imaging	6.21.5

References

https://wanheiqiyihu.top/2023/02/13/Evolucare-Ecsimaging-new-movie-php%E5%8F%8D%E5%B0%84%E6%80%A7xss/Exploit, Third Party Advisory
https://wanheiqiyihu.top/2023/02/13/Evolucare-Ecsimaging-new-movie-php%E5%8F%8D%E5%B0%84%E6%80%A7xss/Exploit, Third Party Advisory

Timeline

Published: Mar 22, 2023
Last Modified: Jun 17, 2026
Status: Modified

Frequently Asked Questions

What is CVE-2023-26913?

EVOLUCARE ECSIMAGING (aka ECS Imaging) < 6.21.5 is vulnerable to Cross Site Scripting (XSS) via new_movie. php.

How severe is CVE-2023-26913?

CVE-2023-26913 has a CVSS score of 6.1/10 (MEDIUM severity). The EPSS model estimates a 0.49% probability of exploitation in the next 30 days.

How do I fix CVE-2023-26913?

Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2023-26913?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST